Thank You for Joining Our Academic Community!

We’re thrilled to welcome you as a new member of our journal. Your support helps advance scholarly research and ensures access to cutting-edge psychiatry articles and insights.

Choose your interests

Depression (MDD)

Schizophrenia/Schizoaffective Disorders

Neurology

Psychiatry

Bipolar Disorder

Suicide

Addiction

Child and Adolescent Psychiatry

Our Recently Published Articles

PCC
Black Hairy Tongue: A Rare Adverse Effect of Olanzapine
Case Report

October 3, 2024

A young woman recently diagnosed with a manic episode developed black discoloration on the dorsum of her tongue 3 weeks after starting olanzapine.
PCC
Age-Friendly Health Systems
Case Report

October 3, 2024

The age-friendly health systems movement promotes 4 evidence-based geriatric care principles known as the “4Ms”: What Matters, Medications, Mobility, and Mentation. Read on to find out more.
JCP
Ketamine/Esketamine in Bipolar Depression in a Clinical Setting
Original Research

October 2, 2024

In a small sample of patients with bipolar depression treated with ketamine/esketamine, no evidence of mania or hypomania was seen during acute treatment.
JCP
Suicide Risk Evaluation and Advanced AI Models
Original Research

October 2, 2024

This study explored how ChatGPT-3.5 and ChatGPT-4 assess suicide risk factors like previous attempts, gender, and age, focusing on their predictions about different types of suicidal behavior.
PCC
Withdrawal Psychosis During a Digital Detoxification Camp
Case Report

October 1, 2024

A 24-year-old woman with a history of depression, anxiety, and ADHD presented with ongoing auditory and visual hallucinations and aggressive behavior that manifested while she was undergoing treatment at…
JCP
Algorithms for TRD Treatment Success
Insights

September 27, 2024

Dr. Nolan Williams delves into the innovative Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treating resistant depression. Explore groundbreaking research, clinical trials, and the transformative potential of personalized brain…
JCP
SSRI Discontinuation and AUD Relapse
Case Report

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to…
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
Clinical and Practical Psychopharmacology

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.
JCP
Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
Commentary

August 21, 2024

Dr Rosenbaum comments on the challenge of evaluating trials of treatments whose effects are unmistakable, and how this dilemma may be addressed.